These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 19942605
1. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report. Haruki S, Minami Y, Kajimoto K, Yashiro B, Suzuki T, Kawana M, Hagiwara N. Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605 [Abstract] [Full Text] [Related]
2. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy. Minami Y, Kajimoto K, Kawana M, Hagiwara N, Sherrid MV. Int J Cardiol; 2010 May 28; 141(2):195-7. PubMed ID: 19097655 [Abstract] [Full Text] [Related]
3. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Circulation; 1994 Dec 28; 90(6):2731-42. PubMed ID: 7994815 [Abstract] [Full Text] [Related]
4. Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting. Sirak TE, Sherrid MV. Chest; 2008 May 28; 133(5):1243-6. PubMed ID: 18460523 [Abstract] [Full Text] [Related]
5. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Circulation; 1992 Jun 28; 85(6):2149-61. PubMed ID: 1350522 [Abstract] [Full Text] [Related]
6. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. Ball W, Ivanov J, Rakowski H, Wigle ED, Linghorne M, Ralph-Edwards A, Williams WG, Schwartz L, Guttman A, Woo A. J Am Coll Cardiol; 2011 Nov 22; 58(22):2313-21. PubMed ID: 22093509 [Abstract] [Full Text] [Related]
7. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study. Galve E, Sambola A, Saldaña G, Quispe I, Nieto E, Diaz A, Evangelista A, Candell-Riera J. Heart; 2010 Mar 22; 96(5):352-6. PubMed ID: 19482844 [Abstract] [Full Text] [Related]
8. Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug. Verlinden NJ, Coons JC. Pharmacotherapy; 2015 Dec 22; 35(12):1164-72. PubMed ID: 26684556 [Abstract] [Full Text] [Related]
9. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. Topilski I, Sherez J, Keren G, Copperman I. Am J Cardiol; 2006 Jun 15; 97(12):1769-75. PubMed ID: 16765132 [Abstract] [Full Text] [Related]
10. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. Matsubara H, Nakatani S, Nagata S, Ishikura F, Katagiri Y, Ohe T, Miyatake K. J Am Coll Cardiol; 1995 Sep 15; 26(3):768-75. PubMed ID: 7642872 [Abstract] [Full Text] [Related]
11. Hypertensive left ventricular hypertrophy with left ventricular outflow tract obstructive physiology: a case of successful treatment with dual-chamber pacing. Wicks AB, Stajduhar K, Mascette A. Mil Med; 1998 Dec 15; 163(12):861-3. PubMed ID: 9866370 [Abstract] [Full Text] [Related]
12. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy. Dimitrow PP, Grodecki J, Bacior B, Dudek D, Legutko J, Jaszcz KK, Dubiel JS. Pacing Clin Electrophysiol; 2000 Sep 15; 23(9):1324-9. PubMed ID: 11025886 [Abstract] [Full Text] [Related]
13. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Lucon A, Palud L, Pavin D, Donal E, Behar N, Leclercq C, Mabo P, Daubert JC. Arch Cardiovasc Dis; 2013 Sep 15; 106(6-7):373-81. PubMed ID: 23806305 [Abstract] [Full Text] [Related]
14. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Dimitrow PP, Podolec P, Grodecki J, Płazak W, Dudek D, Pieniazek P, Bacior B, Legutko J, Olszowska M, Kostkiewicz M, Kawecka-Jaszcz K, Tracz W, Dubiel JS. Int J Cardiol; 2004 Mar 15; 94(1):31-4. PubMed ID: 14996471 [Abstract] [Full Text] [Related]
15. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ. J Am Coll Cardiol; 1997 Feb 15; 29(2):435-41. PubMed ID: 9015001 [Abstract] [Full Text] [Related]
16. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. J Am Coll Cardiol; 2005 Apr 19; 45(8):1251-8. PubMed ID: 15837258 [Abstract] [Full Text] [Related]
17. Sequential Atrioventricular Pacing in Patients With Hypertrophic Cardiomyopathy: An 18-year Experience. Jurado Román A, Montero Cabezas JM, Rubio Alonso B, García Tejada J, Hernández Hernández F, Albarrán González-Trevilla A, Velázquez Martín MT, Coma Samartín R, Rodríguez García J, Tascón Pérez JC. Rev Esp Cardiol (Engl Ed); 2016 Apr 19; 69(4):377-83. PubMed ID: 26719031 [Abstract] [Full Text] [Related]
18. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Rydén L. Eur Heart J; 1997 Apr 19; 18(4):636-42. PubMed ID: 9129895 [Abstract] [Full Text] [Related]
19. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. McAreavey D, Fananapazir L. Am J Cardiol; 1992 Sep 01; 70(6):651-6. PubMed ID: 1510015 [Abstract] [Full Text] [Related]
20. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy. Ranasinghe I, Yeoh T, Yiannikas J. Heart Lung Circ; 2011 Sep 01; 20(9):579-86. PubMed ID: 21684204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]